text:  IL-33 activated lung ILC2s at day 4, biological rep 2 Mus musculus lung ILC2s 4 days after intranasal IL-33 treatment time point: day 4; tissue: lung; cell type: Group 2 innate lymphoid cells; strain: C57BL/6J